Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T14:51:02.703Z.
Calculation as of: 2026-10-06T14:51:02.703Z.
Quote observation: 2026-10-06T14:50:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6c02d81e284155bdcda1783dec911e9c0a395e203238f61c1cccf60d236910ce
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$8.77B
EV/FCF Ratio
111.86x
TTM Avg
1045.31x
3Y Avg
1026.30x
5Y Avg
1026.30x
Market Cap
$8.57B
EV/FCF Ratio
N/A
TTM Avg
127.35x
3Y Avg
127.35x
5Y Avg
75.61x
Market Cap
$9.12B
EV/FCF Ratio
115.54x
TTM Avg
164.71x
3Y Avg
91.71x
5Y Avg
80.37x
Market Cap
$8.40B
EV/FCF Ratio
N/A
TTM Avg
34.26x
3Y Avg
34.16x
5Y Avg
34.16x
Market Cap
$8.18B
EV/FCF Ratio
54.20x
TTM Avg
52.04x
3Y Avg
52.04x
5Y Avg
52.04x
Market Cap
$9.53B
EV/FCF Ratio
35.34x
TTM Avg
39.30x
3Y Avg
42.86x
5Y Avg
42.86x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | $8.79B | N/A | N/A | N/A | N/A |
| Bruker Corporation (BRKRP)vs › | $8.77B | 111.86x | 1045.31x | 1026.30x | 1026.30x |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.57B | N/A | 127.35x | 127.35x | 75.61x |
| Oscar Health, Inc. (OSCR)vs › | $8.47B | 1.11x | 2.20x | 3.82x | 3.92x |
| Bruker Corporation (BRKR)vs › | $9.12B | 115.54x | 164.71x | 91.71x | 80.37x |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.40B | N/A | 34.26x | 34.16x | 34.16x |
| Insulet Corp. (PODD)vs › | $9.34B | 32.69x | 40.51x | 73.82x | 73.82x |
| Caris Life Sciences, Inc. (CAI)vs › | $8.18B | 54.20x | 52.04x | 52.04x | 52.04x |
| Krystal Biotech, Inc. (KRYS)vs › | $9.53B | 35.34x | 39.30x | 42.86x | 42.86x |
| Henry Schein, Inc. (HSIC)vs › | $9.73B | 24.84x | 28.62x | 26.92x | 24.53x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
